Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug ...

Merck presents positive results from phase 3 LITESPARK-022 trial of Keytruda plus Welireg in certain patients with earlier-stage RCC at 2026 ASCO cancers symposium: Rahway, New Je ...

The price for the same prescription drug in different hospitals nationwide could have more than a $10,000 difference, according to a new report. A report from 3 Axis Advisors used publicly available ...

In recent weeks, Merck secured new regulatory milestones for its KEYTRUDA franchise, including U.S. FDA approval for KEYTRUDA ...

An Indian national has been sentenced for conspiring to sell counterfeit cancer drugs in the US, highlighting the dangers of ...

The price for the same prescription drug in different hospitals nationwide could have more than a $10,000 difference, according to a new report.

Indian national Sanjay Kumar has been sentenced to nearly four years in prison for carrying out a conspiracy to sell fake ...

A 45-year-old Indian national, Sanjay Kumar, was sentenced Thursday to 43 months in federal prison for his role in a ...

Ahmedabad: Zydus Lifesciences Limited has successfully completed the pivotal clinical development of its pembrolizumab biosimilar FYB206 and is preparing for a near-term Biologics ...

The leadership changes arrive as BioNTech reported a 57% rise in net losses for 2025.